Groups Feed

A Paradigm Shift: The Evolving Landscape of Anticoagulation in the U.S.

In the U.S. healthcare system, the management of blood clots has undergone a dramatic transformation. What was once a field dominated by a single, decades-old drug is now a dynamic market of new therapies and technologies. Anticoagulation—the use of "blood thinners" to prevent and treat dangerous blood clots—is a multi-billion-dollar industry driven by an aging population, rising rates of chronic disease, and a revolutionary shift from traditional medications to new, more convenient options.

The U.S. accounts for a significant portion of the global anticoagulation market, a testament to the high prevalence of conditions like atrial fibrillation (AFib), deep vein thrombosis (DVT), and pulmonary embolism (PE). This market is not just about the drugs; it also includes the technologies for monitoring and managing therapy.

The Rise of DOACs: A New Standard of Care

For over 60 years, warfarin (Coumadin®) was the…

I've had experience with dogs for years, through habi g my own, helping family woth training there dogs and started taking other people's dogs out at a young age.

I have insurance, provide free water, treats and dog toys

I can look after your dog at my property any length of time, small visits or over night

Welcome to our group Walkies Group! A space for us to connect and share with each other. Start by posting your thoughts, sharing media, or creating a poll.